| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2084 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1501 | 2018 |
| The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 73 (4), 842-854, 2020 | 343 | 2020 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 324 | 2022 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 309 | 2017 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 248* | 2015 |
| PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ... Journal of hepatology 74 (5), 1097-1108, 2021 | 192 | 2021 |
| Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, ... The lancet Gastroenterology & hepatology 3 (2), 125-133, 2018 | 166 | 2018 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 142 | 2015 |
| Circulating markers of liver fibrosis progression P Jarčuška, M Janičko, E Veselíny, P Jarčuška, Ľ Skladaný Clinica Chimica Acta 411 (15-16), 1009-1017, 2010 | 111 | 2010 |
| Coenzyme Q10 and selenium in statin-associated myopathy treatment J Fedacko, D Pella, P Fedackova, O Hänninen, P Tuomainen, P Jarcuska, ... Canadian journal of physiology and pharmacology 91 (2), 165-170, 2013 | 105 | 2013 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2 E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ... Journal of viral hepatitis 22, 46-73, 2015 | 91 | 2015 |
| Chronic hepatitis C association with diabetes mellitus and cardiovascular risk in the era of DAA therapy S Drazilova, J Gazda, M Janicko, P Jarcuska Canadian Journal of Gastroenterology and Hepatology 2018, 2018 | 76 | 2018 |
| Are barriers in accessing health services in the Roma population associated with worse health status among Roma? P Jarcuska, D Bobakova, J Uhrin, L Bobak, I Babinska, P Kolarcik, ... International journal of public health 58, 427-434, 2013 | 75 | 2013 |
| Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients M Janičko, E Veselíny, D Leško, P Jarčuška Annals of hepatology 12 (4), 413-419, 2013 | 57 | 2013 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 56 | 2023 |
| Pleiotropic effects of statins in the diseases of the liver M Janicko, S Drazilova, D Pella, J Fedacko, P Jarcuska World Journal of Gastroenterology 22 (27), 6201, 2016 | 56 | 2016 |
| Is the cardiovascular risk profile of people living in Roma settlements worse in comparison with the majority population in Slovakia? I Babinska, ZD Veselska, D Bobakova, D Pella, S Panico, SA Reijneveld, ... International journal of public health 58, 417-425, 2013 | 56 | 2013 |
| Does the population living in Roma settlements differ in physical activity, smoking and alcohol consumption from the majority population in Slovakia I Babinská, AM Gecková, P Jarcuska, D Pella, M Mareková, G Stefkova, ... Cent Eur J Public Health 22 (Supp. l), P22-7, 2014 | 55 | 2014 |
| Association between hepatitis B and metabolic syndrome: Current state of the art P Jarcuska, S Drazilova, J Fedacko, D Pella, M Janicko World journal of gastroenterology 22 (1), 155, 2016 | 54 | 2016 |
